Covid-fighting drug from S.F. biotech fizzles in late-stage trial By: San Francisco Business Times via Business Journals March 03, 2021 at 13:59 PM EST Enrollment in the NIH trial was stopped, but other studies of the drug are continuing, the companies said. Read More >>
